Indian drug makers looking to expand in Chinese pharma industry
According to a new report, pharma companies in India are increasingly entering the Chinese pharma industry through joint ventures.
List view / Grid view
According to a new report, pharma companies in India are increasingly entering the Chinese pharma industry through joint ventures.
The Middle Eastern country has a limited supply of vital medication needed for conditions such as cancer due to US trade blocks.
FDA approves Nubeqa (darolutamide) as a new treatment for men with non-metastatic castration-resistant prostate cancer.
The global pharmaceutical robots market is set to be worth $344.4m at the end of a forecast period, after seeing substantial growth.
A new study undertaken to better understand the economic impact of brand-brand competition finds this does not lower drug prices.
In another bid to lower medication prices in the US, Donald Trump has announced a draft plan to import drugs from Canada.
A report has suggested that the drug price reforms in the US will affect AstraZeneca and Novartis negatively, but Novo could benefit.
EMA’s human medicines committee had cleared the cannabidiol oral solution, Epidiolex, for use to treat seizures.
Teva Pharmaceuticals, Endo Pharmaceuticals and Teikoku will pay almost $70 million to the US state for delaying drugs to keep prices high.
The EMA has announced its approval for marketing authorisation in the EU for Vitrakvi (larotrectinib), used to treat solid tumours with a specific gene mutation.
The CMA alleges that a pharmaceutical company agreed to buy equal quantities of a pill from two drug suppliers, breaking competition law.
The pharmaceutical processing and packaging equipment market is expected to witness a high increase during the forecast period (2019-2025).
The Senate Finance Committee has unveiled its bipartisan bill in an effort to lower drug prices, requiring drug manufacturers to justify price increases.
FDA issues warning to a company that claimed its CBD products can be used to treat cancer and Alzheimer's disease.
The FDA has announced that it has granted approval to the first nine generic drug applications for Pfizer’s Lyrica treatment.